• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉溶栓后人类“无复流”现象的闪烁扫描证据。

Scintigraphic evidence of the "no reflow" phenomenon in human beings after coronary thrombolysis.

作者信息

Schofer J, Montz R, Mathey D G

出版信息

J Am Coll Cardiol. 1985 Mar;5(3):593-8. doi: 10.1016/s0735-1097(85)80381-8.

DOI:10.1016/s0735-1097(85)80381-8
PMID:3973255
Abstract

To assess whether the absence of new thallium-201 uptake after successful intracoronary thrombolysis reflects a disturbance of myocardial cell function or lack of capillary reperfusion, dual isotope scintigraphic studies with thallium-201 and technetium-99m micro-albumin aggregates were performed in 16 patients with acute anterior myocardial infarction. Intracoronary thallium-201 and technetium-99m scintigraphy performed before intracoronary thrombolysis in 12 of the 16 patients resulted in identical thallium-201 and technetium-99m defect sizes. Immediately after intracoronary thrombolysis, thallium-201 and technetium-99m scintigraphy was repeated in 11 of the 12 patients. In 4 of the 11, the initial thallium and technetium scintigraphic defects were significantly reduced, and in 6 of the 11, they were only slightly reduced; there was no difference in the size of the residual defect as assessed with both radionuclides in all 10 of the 11 patients. In the eleventh patient, there was a significant reduction of the initial technetium-99m scintigraphic defect but no change in the size of the thallium-201 defect. In four other patients, scintigrams were obtained only after intracoronary thrombolysis; these revealed no difference in thallium-201 and technetium-99m defect size. In seven of eight patients restudied 2 to 4 weeks after intracoronary thrombolysis, thallium-201 and technetium-99m defect sizes were identical with those immediately after intracoronary thrombolysis; in the eighth patient there was no difference in thallium-201 and technetium-99m defect size, although such a difference had been present immediately after intracoronary thrombolysis.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

为评估冠状动脉内溶栓成功后新的铊-201摄取缺失是反映心肌细胞功能紊乱还是缺乏毛细血管再灌注,对16例急性前壁心肌梗死患者进行了铊-201和锝-99m微白蛋白聚集物的双同位素闪烁扫描研究。16例患者中有12例在冠状动脉内溶栓前进行了冠状动脉内铊-201和锝-99m闪烁扫描,结果显示铊-201和锝-99m缺损大小相同。在这12例患者中的11例冠状动脉内溶栓后立即重复进行铊-201和锝-99m闪烁扫描。11例中的4例,最初的铊和锝闪烁扫描缺损显著缩小,11例中的6例仅略有缩小;11例中的所有10例患者用两种放射性核素评估的残余缺损大小没有差异。第11例患者,最初的锝-99m闪烁扫描缺损显著缩小,但铊-201缺损大小无变化。另外4例患者仅在冠状动脉内溶栓后进行了闪烁扫描;结果显示铊-201和锝-99m缺损大小无差异。在冠状动脉内溶栓后2至4周重新检查的8例患者中的7例,铊-201和锝-99m缺损大小与冠状动脉内溶栓后立即检查时相同;第8例患者铊-201和锝-99m缺损大小无差异,尽管在冠状动脉内溶栓后立即存在这种差异。(摘要截短于250字)

相似文献

1
Scintigraphic evidence of the "no reflow" phenomenon in human beings after coronary thrombolysis.冠状动脉溶栓后人类“无复流”现象的闪烁扫描证据。
J Am Coll Cardiol. 1985 Mar;5(3):593-8. doi: 10.1016/s0735-1097(85)80381-8.
2
Scintigraphic evidence that the right ventricular myocardium tolerates ischaemia better than the left ventricular myocardium.
Eur Heart J. 1985 Sep;6(9):751-8. doi: 10.1093/oxfordjournals.eurheartj.a061936.
3
Assessment of myocardial necrosis immediately after intracoronary thrombolysis by intracoronary injection of technetium-99m pyrophosphate.通过冠状动脉内注射99m锝焦磷酸盐对冠状动脉内溶栓后即刻心肌坏死进行评估。
Eur Heart J. 1984 Aug;5(8):617-21. doi: 10.1093/oxfordjournals.eurheartj.a061717.
4
Thallium-201/technetium-99m pyrophosphate overlap in patients with acute myocardial infarction after thrombolysis: prediction of depressed wall motion despite thallium uptake.急性心肌梗死后溶栓患者中铊-201/锝-99m焦磷酸盐重叠现象:尽管铊摄取,但对室壁运动减弱的预测
Am Heart J. 1986 Aug;112(2):291-5. doi: 10.1016/0002-8703(86)90264-4.
5
Thrombolysis in acute myocardial infarction using intracoronary streptokinase: assessment by thallium-201 scintigraphy.使用冠状动脉内链激酶进行急性心肌梗死溶栓治疗:通过铊-201闪烁扫描法评估
Circulation. 1982 Sep;66(3):658-64. doi: 10.1161/01.cir.66.3.658.
6
Recovery of left ventricular function after myocardial infarction can be predicted immediately after thrombolysis by semiquantitative intracoronary thallium and technetium pyrophosphate scintigraphy.心肌梗死后左心室功能的恢复可在溶栓后立即通过半定量冠状动脉内铊和焦磷酸锝闪烁显像来预测。
Eur Heart J. 1988 Oct;9(10):1088-97. doi: 10.1093/oxfordjournals.eurheartj.a062404.
7
Assessment of "microvascular no-reflow phenomenon" using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction.利用锝-99m 大颗粒聚合白蛋白闪烁扫描术评估急性心肌梗死患者的“微血管无复流现象”
J Am Coll Cardiol. 1998 Oct;32(4):898-903. doi: 10.1016/s0735-1097(98)00435-5.
8
Use of dual intracoronary scintigraphy with thallium-201 and technetium-99m pyrophosphate to predict improvement in left ventricular wall motion immediately after intracoronary thrombolysis in acute myocardial infarction.使用铊-201和锝-99m焦磷酸盐进行双冠状动脉闪烁显像以预测急性心肌梗死冠状动脉内溶栓后即刻左心室壁运动的改善情况。
J Am Coll Cardiol. 1983 Oct;2(4):737-44. doi: 10.1016/s0735-1097(83)80314-3.
9
Implications of delayed image on simultaneous thallium-201/technetium-99m pyrophosphate dual emission computed tomography early after acute myocardial infarction.急性心肌梗死后早期,延迟显像对铊-201/焦磷酸锝-99m双发射计算机断层显像同步检查的影响
Jpn Circ J. 1993 Jan;57(1):27-36. doi: 10.1253/jcj.57.27.
10
Comparison of the predischarge exercise thallium-201 perfusion defect after myocardial infarction with myocardium at risk measured during acute infarction with technetium-99m sestamibi imaging.心肌梗死后出院前运动铊-201灌注缺损与急性心肌梗死期间用锝-99m司他比显像测量的危险心肌的比较。
Am Heart J. 2003 Feb;145(2):357-63. doi: 10.1067/mhj.2003.21.

引用本文的文献

1
Sex-based Differences in Complications Following Percutaneous Coronary Interventions.经皮冠状动脉介入治疗后并发症的性别差异。
Curr Atheroscler Rep. 2025 Feb 17;27(1):33. doi: 10.1007/s11883-025-01278-y.
2
The Role of Microvascular Obstruction and Intra-Myocardial Hemorrhage in Reperfusion Cardiac Injury. Analysis of Clinical Data.微血管阻塞和心肌内出血在再灌注性心脏损伤中的作用。临床数据分析。
Rev Cardiovasc Med. 2024 Mar 14;25(3):105. doi: 10.31083/j.rcm2503105. eCollection 2024 Mar.
3
The Use of Thrombectomy during Primary Percutaneous Coronary Intervention: Resurrecting an Old Concept in Contemporary Practice.
在直接经皮冠状动脉介入治疗中使用血栓切除术:在当代实践中重拾一个旧概念。
J Clin Med. 2024 Apr 15;13(8):2291. doi: 10.3390/jcm13082291.
4
Coronary no-reflow and adverse events in patients with acute myocardial infarction after percutaneous coronary intervention with current drug-eluting stents and third-generation P2Y inhibitors.现行药物洗脱支架和第三代 P2Y 抑制剂经皮冠状动脉介入治疗后急性心肌梗死患者的冠状动脉无复流和不良事件。
Clin Res Cardiol. 2024 Jul;113(7):1006-1016. doi: 10.1007/s00392-023-02340-y. Epub 2023 Nov 14.
5
Coronary No-Reflow after Primary Percutaneous Coronary Intervention-Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy.直接经皮冠状动脉介入治疗后的冠状动脉无复流——关于病理生理学、诊断、临床影响及治疗的当前认知
J Clin Med. 2023 Aug 27;12(17):5592. doi: 10.3390/jcm12175592.
6
A historical literature review of coronary microvascular obstruction and intra-myocardial hemorrhage as functional/structural phenomena.冠状动脉微血管阻塞和心肌内出血作为功能/结构现象的历史文献综述
J Biomed Res. 2023 Jul 28;37(4):281-302. doi: 10.7555/JBR.37.20230021.
7
Pathophysiology, Diagnosis, and Management of Coronary No-Reflow Phenomenon.冠状动脉无复流现象的病理生理学、诊断与处理
Int J Angiol. 2022 Jan 13;31(2):107-112. doi: 10.1055/s-0041-1735949. eCollection 2022 Jun.
8
A Narrative Review of the Classical and Modern Diagnostic Methods of the No-Reflow Phenomenon.无复流现象的经典与现代诊断方法的叙述性综述
Diagnostics (Basel). 2022 Apr 8;12(4):932. doi: 10.3390/diagnostics12040932.
9
Pathophysiology, Diagnosis, and Management of Coronary No-Reflow Phenomenon.冠状动脉无复流现象的病理生理学、诊断与管理
Int J Angiol. 2021 Mar;30(1):15-21. doi: 10.1055/s-0041-1725979. Epub 2021 Mar 3.
10
No Reflow in Acute Coronary Syndromes: An Old Foe or a New Frontier?急性冠状动脉综合征中的无复流现象:是老问题还是新领域?
Arq Bras Cardiol. 2021 May;116(5):968-969. doi: 10.36660/abc.20210118.